Basic Information
Aflunov
Regulatory Information
November 4, 2024
Active Substances Detail
influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: A/turkey/Turkey/1/05 (H5N1)-like strain (NIBRG-23)
EMA Resources
Detailed Information
Therapeutic Indication
### Therapeutic indication Active immunisation against H5N1 subtype of Influenza A virus in individuals 6 months of age and above. Aflunov should be used in accordance with official recommendations.
Overview Summary
Aflunov is a vaccine used in adults and children above the age of 6 months to protect against flu caused by the H5N1 (‘bird flu’) strain of the influenza A virus. Aflunov contains parts of influenza (flu) viruses that have been inactivated (killed). Aflunov contains parts from a flu strain called A/turkey/Turkey/1/2005 (H5N1)-like strain (NIBRG-23). (clade 2.2.1).